Cutaneous vasculitis associated with zafirlukast use in asthma.
Al-Herz
Waleed
W
Division of Allergy and Clinical Immunology, Alfred I. duPont Hospital for Children, Wilmington, Delaware 19803, USA.
Rosé
Carlos
C
McGeady
Stephen J
SJ
D001249:Asthma / Q000188:drug therapy; D002648:Child; D006801:Humans; D007211:Indoles; D020024:Leukotriene Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced*
D007211:Indoles; D020024:Leukotriene Antagonists; D048448:Phenylcarbamates; D013449:Sulfonamides; D014105:Tosyl Compounds; C062735:zafirlukast